Genomics testing advances need to be translated into medical practice now
This article was originally published in Clinica
Executive Summary
In 2000, the then UK Prime Minister Tony Blair was all too happy to describe the completion of the first draft of the human genome sequence as “the most wondrous map ever produced by humankind”. Considering the extraordinary amount of public and private funding that molecular diagnostics and pharmacogenomics have received over the last two decades, it should be self-evident that the benefits would need to be translated quickly into clinical practice as they become available.